Majerciak V, Zheng Z
Hlife. 2025; 3(1):21-37.
PMID: 40078969
PMC: 11902918.
DOI: 10.1016/j.hlife.2024.11.005.
Cyr P, Fader L, Burch J, Pike K, Sietsema D, Boily M
ACS Med Chem Lett. 2024; 15(12):2201-2209.
PMID: 39691514
PMC: 11647726.
DOI: 10.1021/acsmedchemlett.4c00471.
Tolbert E, Dacus D, Pollina R, Wallace N
bioRxiv. 2024; .
PMID: 39677810
PMC: 11642751.
DOI: 10.1101/2024.11.29.625575.
Bechon N, Tal N, Stokar-Avihail A, Savidor A, Kupervaser M, Melamed S
Nat Commun. 2024; 15(1):9860.
PMID: 39543107
PMC: 11564622.
DOI: 10.1038/s41467-024-54214-0.
Manetsch P, Hottiger M
Bioessays. 2024; 47(2):e2400087.
PMID: 39502005
PMC: 11755700.
DOI: 10.1002/bies.202400087.
ZNFX1 is a Novel Master Regulator in Epigenetically-induced Pathogen Mimicry and Inflammasome Signaling in Cancer.
Stojanovic L, Abbotts R, Tripathi K, Coon C, Rajendran S, Abbasi Farid E
bioRxiv. 2024; .
PMID: 39484607
PMC: 11526927.
DOI: 10.1101/2024.10.18.618659.
Retrotransposons are co-opted to activate hematopoietic stem cells and erythropoiesis.
Phan J, Chen B, Zhao Z, Allies G, Iannaccone A, Paul A
Science. 2024; 386(6722):eado6836.
PMID: 39446896
PMC: 11709122.
DOI: 10.1126/science.ado6836.
DNA sensors in metabolic and cardiovascular diseases: Molecular mechanisms and therapeutic prospects.
Kwak H, Lee E, Karki R
Immunol Rev. 2024; 329(1):e13382.
PMID: 39158380
PMC: 11744256.
DOI: 10.1111/imr.13382.
A time series transcriptome profiling of host cell responses to Newcastle disease virus infection.
Nayak B, Palanisamy P, Venkataraman S, Subbiah M
Arch Virol. 2024; 169(9):175.
PMID: 39117748
DOI: 10.1007/s00705-024-06100-9.
Immunostimulatory nucleic acid nanoparticles (NANPs) augment protective osteoblast and osteoclast type I interferon responses to Staphylococcus aureus.
Mills E, Avila Y, Beasock D, Radwan Y, Suptela S, Marriott I
Nanomedicine. 2024; 60:102762.
PMID: 38866196
PMC: 11297679.
DOI: 10.1016/j.nano.2024.102762.
Structural and mechanistic insights into disease-associated endolysosomal exonucleases PLD3 and PLD4.
Yuan M, Peng L, Huang D, Gavin A, Luan F, Tran J
Structure. 2024; 32(6):766-779.e7.
PMID: 38537643
PMC: 11162324.
DOI: 10.1016/j.str.2024.02.019.
Type I IFN in Glomerular Disease: Scarring beyond the STING.
Jimenez-Uribe A, Mangos S, Hahm E
Int J Mol Sci. 2024; 25(5).
PMID: 38473743
PMC: 10931919.
DOI: 10.3390/ijms25052497.
Understanding nucleic acid sensing and its therapeutic applications.
Kong L, Kim S, Wang C, Lee S, Oh S, Lee S
Exp Mol Med. 2023; 55(11):2320-2331.
PMID: 37945923
PMC: 10689850.
DOI: 10.1038/s12276-023-01118-6.
The cGAS/STING/IFN-1 Response in Squamous Head and Neck Cancer Cells after Genotoxic Challenges and Abrogation of the ATR-Chk1 and Fanconi Anemia Axis.
Zahnreich S, El Guerzyfy S, Kaufmann J, Schmidberger H
Int J Mol Sci. 2023; 24(19).
PMID: 37834346
PMC: 10573837.
DOI: 10.3390/ijms241914900.
Synthesis and validation of click-modified NOD1/2 agonists.
Bharadwaj R, Anonick M, Jaiswal S, Mashayekh S, Brown A, Wodzanowski K
Innate Immun. 2023; 29(8):186-200.
PMID: 37828863
PMC: 10621468.
DOI: 10.1177/17534259231207198.
Influence of the Composition of Cationic Liposomes on the Performance of Cargo Immunostimulatory RNA.
Bishani A, Makarova D, Shmendel E, Maslov M, Senkova A, Savin I
Pharmaceutics. 2023; 15(9).
PMID: 37765155
PMC: 10535620.
DOI: 10.3390/pharmaceutics15092184.
RNA-based medicine: from molecular mechanisms to therapy.
Sparmann A, Vogel J
EMBO J. 2023; 42(21):e114760.
PMID: 37728251
PMC: 10620767.
DOI: 10.15252/embj.2023114760.
Secretion of mitochondrial DNA via exosomes promotes inflammation in Behçet's syndrome.
Konaka H, Kato Y, Hirano T, Tsujimoto K, Park J, Koba T
EMBO J. 2023; 42(20):e112573.
PMID: 37661814
PMC: 10577637.
DOI: 10.15252/embj.2022112573.
The interferon-stimulated genes are plausibly a primary genetic locus for genetically enabling hyperinflammatory and autoimmune diseases and lymphocyte exhaustion.
Roe K
Hum Cell. 2023; 36(6):2278-2280.
PMID: 37624513
DOI: 10.1007/s13577-023-00969-5.
IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment.
Elcheva I, Gowda C, Bogush D, Gornostaeva S, Fakhardo A, Sheth N
Front Immunol. 2023; 14:1224516.
PMID: 37503349
PMC: 10369348.
DOI: 10.3389/fimmu.2023.1224516.